ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that multiple abstracts ...
A foundational guide for stage 2 prostate cancer clarifies staging implications, localized-disease management, and trade-offs among surgery, radiation, and quality-of-life outcomes to support informed ...
A new study co-authored by University of Kentucky Markey Cancer Center researchers Jessica Burris, Ph.D., Timothy Mullett, M.D., and Graham Warren, M.D., Ph.D., shows that making smoking cessation ...
The Lehigh Valley Auto Show showcases innovation, creativity, and automotive excellence, drawing car enthusiasts from across the region. This year, it will also put men’s health in the spotlight with ...
Healthcare provider, LivingCare Group has been selected as the proposed imaging partner for the IMProVE clinical trial, a prostate cancer early-detection programme funded by Yorkshire Cancer Research.
A 1951 CIA report on parasites and tumors spread online in March 2026 — but it was declassified years ago and does not reveal a cancer cure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results